List of works - Deniz C Guven

Analysis of Fusobacterium nucleatum and Streptococcus gallolyticus in saliva of colorectal cancer patients

scientific article published on 03 June 2019

COVID-19 pandemic: changes in cancer admissions

scientific article published on 14 July 2020

Cancer incidence in Behçet's disease

scientific article published on 08 May 2020

Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia

scientific article published on 25 April 2019

Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report

scientific article published on 18 October 2020

Complete responses to two different anti-PD1 agents in a metastatic melanoma patient

scientific article published on 29 June 2019

Development of de novo psoriasis during nivolumab therapy in a patient with small cell lung cancer

scientific article published on 29 September 2019

Evaluation of cancer risk in patients with periodontal diseases

scientific article published on 18 June 2019

Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors

scientific article published on 26 August 2020

Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy

scientific article published on 17 June 2019

Fusobacterium and colorectal carcinogenesis

scientific article published in January 2018

Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards

scientific article published in 2021

Nivolumab for the salvage treatment of desperate germ cell tumor: A case report

scientific article published on 06 December 2020

Non-inferiority for Short-HER or short-chemotherapy?

scientific article published on 01 January 2019

Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma

scientific article published on 17 November 2019

Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives

scientific article published on 16 October 2020

The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters

scientific article published on 19 August 2020

The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters

scientific article published on 04 December 2020

Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

scientific article published on 30 August 2020

List of works by Deniz C Guven

Analysis of Fusobacterium nucleatum and Streptococcus gallolyticus in saliva of colorectal cancer patients

COVID-19 pandemic: changes in cancer admissions

Cancer incidence in Behçet's disease

Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia

Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report

Complete responses to two different anti-PD1 agents in a metastatic melanoma patient

Development of de novo psoriasis during nivolumab therapy in a patient with small cell lung cancer

Evaluation of cancer risk in patients with periodontal diseases

Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors

Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy

Fusobacterium and colorectal carcinogenesis

Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards

Nivolumab for the salvage treatment of desperate germ cell tumor: A case report

Non-inferiority for Short-HER or short-chemotherapy?

Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma

Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives

The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters

The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters

Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)